Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Pediatrics
Published in: BMC Pediatrics 1/2018

Open Access 01-12-2018 | Research article

Indirect neonatal hyperbilirubinemia in hospitalized neonates on the Thai-Myanmar border: a review of neonatal medical records from 2009 to 2014

Authors: L. Thielemans, M. Trip-Hoving, J. Landier, C. Turner, T. J. Prins, E. M. N. Wouda, B. Hanboonkunupakarn, C. Po, C. Beau, M. Mu, T. Hannay, F. Nosten, B. Van Overmeire, R. McGready, V. I. Carrara

Published in: BMC Pediatrics | Issue 1/2018

Login to get access

Abstract

Background

Indirect neonatal hyperbilirubinemia (INH) is a common neonatal disorder worldwide which can remain benign if prompt management is available. However there is a higher morbidity and mortality risk in settings with limited access to diagnosis and care. The manuscript describes the characteristics of neonates with INH, the burden of severe INH and identifies factors associated with severity in a resource-constrained setting.

Methods

We conducted a retrospective evaluation of anonymized records of neonates hospitalized on the Thai-Myanmar border. INH was defined according to the National Institute for Health and Care Excellence guidelines as ‘moderate’ if at least one serum bilirubin (SBR) value exceeded the phototherapy threshold and as ‘severe’ if above the exchange transfusion threshold.

Results

Out of 2980 records reviewed, 1580 (53%) had INH within the first 14 days of life. INH was moderate in 87% (1368/1580) and severe in 13% (212/1580). From 2009 to 2011, the proportion of severe INH decreased from 37 to 15% and the mortality dropped from 10% (8/82) to 2% (7/449) coinciding with the implementation of standardized guidelines and light-emitting diode (LED) phototherapy. Severe INH was associated with: prematurity (< 32 weeks, Adjusted Odds Ratio (AOR) 3.3; 95% CI 1.6–6.6 and 32 to 37 weeks, AOR 2.2; 95% CI 1.6–3.1), Glucose-6-phosphate dehydrogenase deficiency (G6PD) (AOR 2.3; 95% CI 1.6–3.3), potential ABO incompatibility (AOR 1.5; 95% CI 1.0–2.2) and late presentation (AOR 1.8; 95% CI 1.3–2.6). The risk of developing severe INH and INH-related mortality significantly increased with each additional risk factor.

Conclusion

INH is an important cause of neonatal hospitalization on the Thai-Myanmar border. Risk factors for severity were similar to previous reports from Asia. Implementing standardized guidelines and appropriate treatment was successful in reducing mortality and severity. Accessing to basic neonatal care including SBR testing, LED phototherapy and G6PD screening can contribute to improve neonatal outcomes.
Appendix
Available only for authorised users
Literature
1.
Bhutani VK, Zipursky A, Blencowe H, Khanna R, Sgro M, Ebbesen F, et al. Neonatal hyperbilirubinemia and rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels. Pediatr Res. 2013;74(Suppl 1):86–100.CrossRefPubMedPubMedCentral
2.
Shapiro SM. Chronic bilirubin encephalopathy: diagnosis and outcome. Semin Fetal Neonatal Med. 2010;15:157–63. Elsevier LtdCrossRefPubMed
3.
Radmacher PG, Groves FD, Owa JA, Ofovwe GE, Amuabunos EA, Olusanya BO, et al. A modified bilirubin-induced neurologic dysfunction (BIND-M) algorithm is useful in evaluating severity of jaundice in a resource-limited setting. BMC Pediatr. 2015;15:1–7.CrossRef
4.
Johnson L, Bhutani VK, Karp K, Sivieri EM, Shapiro SM. Clinical report from the pilot USA kernicterus registry (1992 to 2004). J Perinatol. 2009;29(Suppl 1):S25–45.CrossRefPubMed
5.
Lawn JE, Blencowe H, Oza S, You D, Lee ACC, Waiswa P, et al. Every newborn: progress, priorities, and potential beyond survival. Lancet. 2014;384:189–205.CrossRefPubMed
6.
Greco C, Arnolda G, Boo NY, Iskander IF, Okolo AA, Rohsiswatmo R, et al. Neonatal jaundice in low- and middle-income countries: lessons and future directions from the 2015 don Ostrow Trieste yellow retreat. Neonatology. 2016;110:172–80.CrossRefPubMed
7.
Blencowe H, Cousens S, Oestergaard MZ, Chou D, Moller AB, Narwal R, et al. National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications. Lancet. 2012;379:2162–72.CrossRefPubMed
8.
Howes RE, Piel FBFB, Patil AP, Nyangiri OA, Gething PW, Dewi M, et al. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med. 2012;9(11):e1001339.CrossRefPubMedPubMedCentral
9.
Bhutani VK. Editorial: building evidence to manage newborn jaundice worldwide. Indian J Pediatr. 2012;79(2):253–5.CrossRefPubMed
10.
Naghavi M, Wang H, Lozano R, Davis A, Liang X, Zhou M, et al. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;385:117–71.CrossRef
11.
Arnolda G, Nwe HM, Trevisanuto D, Thin AA, Thein AA, Defechereux T, et al. Risk factors for acute bilirubin encephalopathy on admission to two Myanmar national paediatric hospitals. Maternal health, neonatology and perinatology. 2015;1:22.CrossRefPubMedPubMedCentral
12.
Department of Public Health in collaboration with Department of Medical Services. Ministry of Health, Annual Report, 2012–2013: The Republic of the Union of Myanmar; 2013. Available at http://​www.​mohs.​gov.​mm/​.
13.
Turner C, Carrara V, Thein NA, Win NC, Turner P, Bancone G, et al. Neonatal intensive Care in a Karen Refugee Camp: a 4 year descriptive study. PLoS One. 2013;8:1–9.
14.
McGready R, Paw MK, Wiladphaingern J, Min AM, Carrara VI, Moore KA, et al. Miscarriage, stillbirth and neonatal mortality in the extreme preterm birth window of gestation in a limited-resource setting on the Thailand-Myanmar border: a population cohort study. Wellcome Open Res. 2016;1:32.
15.
Oo NN, Bancone G, Maw LZ, Chowwiwat N, Bansil P, Domingo GJ, et al. Validation of G6PD point-of-care tests among healthy volunteers in Yangon, Myanmar. PLoS One. 2016;11:e0152304.CrossRefPubMedPubMedCentral
16.
Webster J, Blythe R, Nugent F. An appraisal of the use of the Kramer’s scale in predicting hyperbilirubinaemia in healthy full term infants. Birth Issues. 2006;14:83–9.
17.
18.
Rijken MJ, Mulder EJH, Papageorghiou AT, Thiptharakun S, Wah N, Paw TK, et al. Quality of ultrasound biometry obtained by local health workers in a refugee camp on the Thai-Burmese border. Ultrasound Obstet Gynecol. 2012;40:151–7.CrossRefPubMedPubMedCentral
19.
Moore KA, Simpson JA, Thomas KH, Rijken MJ, White LJ, Lu Moo Dwell S, et al. Estimating gestational age in late presenters to antenatal care in a resource-limited setting on the Thai-Myanmar border. PLoS One. 2015;10:1–17.
20.
Howson CP, Kinney MV, Lawn JE, editors. Born too soon: the global action report on preterm birth. Geneva: World Health Organization; 2012. p. 1–26.
21.
Turner C, Carrara V, Aye N, Thien M, Moo N, Paw K, et al. Changes in the body weight of term infants, born in the tropics, during the first seven days of life. BMC Pediatr. 2013;13(1):93.CrossRefPubMedPubMedCentral
22.
Rijken MJ, Rijken JA, Papageorghiou AT, Kennedy SH, Visser GHA, Nosten F, et al. Malaria in pregnancy: the difficulties in measuring birthweight. BJOG Int J Obstet Gynaecol. 2011;118(6):671–8.CrossRef
23.
Villar J, Cheikh Ismail L, Victora CG, Ohuma EO, Bertino E, Altman DG, et al. International standards for newborn weight, length, and head circumference by gestational age and sex: the newborn cross-sectional study of the INTERGROWTH-21st project. The Lancet. 2014;384:857–68.CrossRef
24.
Mya-Tu M, May-May-Yi M, Thin-Thin-Hlaing T. Blood groups of the Burmese population. Hum Hered. 1971;21:420–30.CrossRefPubMed
25.
26.
Slusher TM, Zamora TG, Appiah D, Stanke JU, Strand MA, Lee BW, et al. Burden of severe neonatal jaundice: a systematic review and meta-analysis. BMJ Paediatr Open. 2017;1:e000105.CrossRefPubMedPubMedCentral
27.
Szabo P, Wolf M, Bucher HU, Fauchère JC, Haensse D, Arlettaz R. Detection of hyperbilirubinaemia in jaundiced full-term neonates by eye or by bilirubinometer? Eur J Pediatr. 2004;163:722–7.CrossRefPubMed
28.
Keren R, Tremont K, Luan X, Cnaan A. Visual assessment of jaundice in term and late preterm infants. Arch Dis Child Fetal Neonatal Ed. 2009;94:F317–22.CrossRefPubMed
29.
Tikmani SS, Warraich HJ, Abbasi F, Rizvi A, Darmstadt GL, Zaidi AKM. Incidence of neonatal hyperbilirubinemia: a population-based prospective study in Pakistan. Trop Med Int Heal. 2010;15:502–7.CrossRef
30.
Sherbiny HS, Youssef DM, Sherbini AS, El-behedy R, Sherief LM. High-intensity light-emitting diode vs fluorescent tubes for intensive phototherapy in neonates. Paediatrics and international child health. 2016;36(2):127–34.CrossRefPubMed
31.
Arnolda G, Thein AA, Trevisanuto D, Aung N, Nwe HM, Thin AA, et al. Evaluation of a simple intervention to reduce exchange transfusion rates among inborn and outborn neonates in Myanmar, comparing pre- and post-intervention rates. BMC Pediatr. 2015;15:216.CrossRefPubMedPubMedCentral
32.
Olusanya BO, Osibanjo FB, Slusher TM. Risk factors for severe neonatal hyperbilirubinemia in low and middle-income countries: a systematic review and meta-analysis. PLoS One. 2015;10(2):e0117229.CrossRefPubMedPubMedCentral
33.
Bancone G, Chu CS, Somsakchaicharoen R, Chowwiwat N, Parker DM, Charunwatthana P, et al. Characterization of G6PD genotypes and phenotypes on the northwestern Thailand-Myanmar border. PLoS One. 2014;9:e116063.CrossRefPubMedPubMedCentral
34.
Bancone G, Gilder ME, Chowwiwat N, Gornsawun G, Win E, Cho WW, et al. Prevalences of inherited red blood cell disorders in pregnant women of different ethnicities living along the Thailand-Myanmar border. Wellcome Open Res. 2017;2:1–17.CrossRef
35.
Prins TJ, Trip-Hoving M, Paw MK, Le Ka M, Win NN, Htoo G, et al. A survey of practice and knowledge of refugee and migrant pregnant mothers surrounding neonatal jaundice on the Thailand-Myanmar border. J Trop Pediatr. 2017;63:50–6. Oxford University PressCrossRefPubMed
36.
Thielemans L, Gornsawun G, Hanboonkunupakarn B, Paw MK, Porn P, Moo PK, et al. Diagnostic performances of the fluorescent spot test for G6PD deficiency in newborns along the Thailand-Myanmar border: a cohort study. Wellcome Open Res. 2018;3:1.CrossRefPubMedPubMedCentral
37.
Kaplan M, Hammerman C. Glucose-6-phosphate dehydrogenase deficiency and severe neonatal hyperbilirubinemia: a complexity of interactions between genes and environment. Semin Fetal Neonatal Med. 2010;15:148–56. Elsevier LtdCrossRefPubMed
38.
Badejoko BO, Owa JA, Oseni SBA, Badejoko O, Fatusi AO, Adejuyigbe EA. Early neonatal bilirubin, hematocrit, and Glucose-6-phosphate dehydrogenase status. Pediatrics. 2014;134:e1082–8.CrossRefPubMed
39.
Kaplan M, Herschel M, Hammerman C, Hoyer JD, Stevenson DK. Hyperbilirubinemia among African American, glucose-6-phosphate dehydrogenase-deficient neonates. Pediatrics. 2004;114:e213–9.CrossRefPubMed
40.
Watchko JF, Kaplan M, Stark AR, Stevenson DK, Bhutani VK. Should we screen newborns for glucose-6-phosphate dehydrogenase deficiency in the United States? J Perinatol. 2013;33:499–504. Nature Publishing GroupCrossRefPubMed
41.
Olusanya BO, Osibanjo FB, Mabogunje CA, Slusher TM, Olowe SA. The burden and management of neonatal jaundice in Nigeria: a scoping review of the literature. Niger J Clin Pract. 2016;19(1):1–7.CrossRefPubMed
42.
Malla T, Singh S, Poudyal P, Sathian B, Bk G, Malla KKA. Prospective study on exchange transfusion in neonatal unconjugated hyperbilirubinemia--in a tertiary care hospital, Nepal. Kathmandu Univ Med J. 2015;13:102–8.CrossRef
43.
Singla DA, Sharma S, Sharma M, Chaudhary S. Evaluation of risk factors for exchange range hyperbilirubinemia and neurotoxicity in neonates from hilly terrain of India. Int J Appl basic Med Res. 2017;7:228–32. Wolters Kluwer -- Medknow PublicationsCrossRefPubMedPubMedCentral
44.
Cherepnalkovski AP, Krzelj V, Zafirovska-ivanovska B, Gruev T, Markic J, et al. Evaluation of neonatal laboratory parameters hemolytic Jaundice : clinical and laboratory parameters. OA Maced J Med Sci. 2015;3:694–8.CrossRef
45.
Chen S-H, Lin M, Yang K-L, Lin T-Y, Tsai H-H, Yang S-H, et al. Association of ABO incompatibility with red blood cell indices of cord blood unit. Pediatr Neonatol. 2012;53:138–43.CrossRefPubMed
46.
Cherepnalkovski AP, Krzelj V, Zafirovska-ivanovska B, Gruev T, Markic J, Aluloska N, et al. Evaluation of neonatal laboratory parameters hemolytic Jaundice: clinical and laboratory parameters. OA Maced J Med Sci. 2015;3:694–8.CrossRef
47.
Olusanya BO, Slusher TM. Infants at risk of significant hyperbilirubinemia in poorly-resourced countries: evidence from a scoping review. World J Pediatr. 2015;11:293–9.CrossRefPubMed
48.
Kaplan M, Herschel M, Hammerman C, Hoyer JD, Heller GZ, Stevenson DK. Neonatal hyperbilirubinemia in African American males: the importance of glucose-6-phosphate dehydrogenase deficiency. J Pediatr. 2006;149:83–8. ElsevierCrossRefPubMed
49.
Norman M, Åberg K, Holmsten K, Weibel V, Ekéus C. Predicting nonhemolytic neonatal hyperbilirubinemia. Am Acad Pediatr. 2015;136:1087–94.
50.
Lee BK, Le Ray I, Sun JY, Wikman A, Reilly M, Johansson S. Haemolytic and nonhaemolytic neonatal jaundice have different risk factor profiles. Acta Paediatr. 2016;105:1444–50.CrossRefPubMed
51.
Kaplan M, Hammerman C, Bhutani VK. Parental education and the WHO neonatal G-6-PD screening program: a quarter century later. J Perinatol. 2015;35:779–84. Nature Publishing GroupCrossRefPubMed
52.
Bhutani VK, Wong RJ, Stevenson DK. Hyperbilirubinemia in Preterm Neonates. Clin Perinatol. 2016;43(2):215–32.CrossRefPubMed
53.
Davies MW, Okwundu CI, Okoromah CAN, Shah PS. Cochrane review: prophylactic phototherapy for preventing jaundice in preterm or low birth weight infants. Evidence-Based Child Heal. 2013;8:204–49.CrossRef
Metadata
Title
Indirect neonatal hyperbilirubinemia in hospitalized neonates on the Thai-Myanmar border: a review of neonatal medical records from 2009 to 2014
Authors
L. Thielemans
M. Trip-Hoving
J. Landier
C. Turner
T. J. Prins
E. M. N. Wouda
B. Hanboonkunupakarn
C. Po
C. Beau
M. Mu
T. Hannay
F. Nosten
B. Van Overmeire
R. McGready
V. I. Carrara
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2018
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-018-1165-0

Other articles of this Issue 1/2018

BMC Pediatrics 1/2018 Go to the issue

Study protocol

Identifying the etiology and pathophysiology underlying stunting and environmental enteropathy: study protocol of the AFRIBIOTA project

Case report

Isolated neonatal bilateral vocal cord paralysis revealing a unilateral medullary defect: a case report

Research article

Examining the challenges posed to parents by the contemporary screen environments of children: a qualitative investigation

Research article

Forehead or ear temperature measurement cannot replace rectal measurements, except for screening purposes

Case report

Chylopericardium in a child with IgA nephropathy: a case report

Research article

Variations in the rancid-flavor compounds of human breastmilk under general frozen-storage conditions